Capitalising on UK’s goal to become a world-leading clinical trial destination
Representatives of industry and regulation will meet in June to discuss paths forward for the UK’s clinical trials sector following…
Featured
-
-
Can AI replace medical writers? Experts say not immediately
AI is said to be exponentially faster and effective at writing lengthy and complex clinical trial documents, but those using…
-
Korean medtech poised to support struggling dementia care in the UK
Under the mounting strain of an aging population, the UK could look to South Korean medtech innovation to ease the…
-
EU Health Data Space strikes a chord in EU harmonisation plans
Amidst a wave of regulatory changes in the European Union (EU) that are underway, the new EU Health Data Space…
-
Amid deglobalising trade, experts seek AI safeguards for clinical trial supply
The role of AI in supply chain management proved to be the focal issue at the recent 2025 Clinical Trial…
-
Worldwide 2024 elections pose pivotal shifts in life sciences and healthcare
The outcomes of this year’s US, EU, and UK elections and their downstream effects will lead to drastic changes to…
-
Are dry powder inhalers the key to sustainable respiratory care?
In a bid to improve the pharma sector’s drive to cut down greenhouse emissions, several companies are advancing dry powder…
-
New Labour government backs pharma reform in UK
“Change begins now,” said the UK’s new prime minister, Sir Keir Starmer, in his 5 July victory speech. Ending the…
-
Pharma and medtech companies need to team up for wound management
There is a critical need for collaboration between the pharmaceutical and medical device industries to develop wound management solutions, says…
-
Biotechs must prioritise ethics to deter GenAI “bad actors”
AI developers in the biotechnology field need to watch out for potential “bad actors”, who could use the technology for…
